Table 5.
Synthetic cannabinoids detected by liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF/MS) in serum collected from patients with synthetic cannabinoid-associated illness—University of Mississippi medical center (UMMC), April 2–May 3, 2015.
| Synthetic cannabinoid detected | Number (% of total patients testing positive for synthetic cannabinoids, n = 39)a |
|---|---|
|
| |
| MAB-CHMINACA | 33 (85) |
| 5-fluoro-THJ | 8 (21) |
| AM 2201 N-(3-chloropentyl) isomer | 5 (13) |
| AB-PINACA | 4 (10) |
| AB-CHMINACA | 3 (8) |
| AM 1248 | 2 (5) |
| Other | 3 (8) |
17 (44%) patients tested positive for multiple synthetic cannabinoids. MAB-CHMINACA = N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexyl-methyl)-1H-indazole-3-carboxamide.
5-fluoro-THJ =1-(5-fluoropentyl)-N-(quinolin-8-yl)-1H-indazole-3-carboxamide.
AM 2201 N-(3-chloropentyl) isomer = (1-(3-chloropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone.
AB-PINACA = (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide.
AB-CHMINACA = N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexyl-methyl)-1H-indazole-3-carboxamide.
AM 1248 = 1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]tricyclo[3.3.1.13,7]-dec-1-yl-methanone.